NASDAQ
Aktis Oncology, Inc. (AKTS) has a current ratio of 7.37x as of Monday, May 25, 2026. This represents a 61.31% decrease compared to its 12-month average of 19.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.